Drug recall · June 5, 2024
Metoprolol Tartrate Tablets USP recall
Why: Presence of Foreign Substance: metal in tablet
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00
- Lots / codes
Lot 231037H1, exp 6/2027
- Quantity
- 11,664 Bottles
- Company
- Rubicon Research Private Limited, Ambarnath
- Distribution
- Nationwide
- Initiated
- May 6, 2024 · Voluntary: Firm initiated
- Classified
- May 29, 2024
- Reported
- June 5, 2024
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.